CN105001213B - C-芳基糖苷衍生物、其药物组合物、制备方法及应用 - Google Patents
C-芳基糖苷衍生物、其药物组合物、制备方法及应用 Download PDFInfo
- Publication number
- CN105001213B CN105001213B CN201410392098.XA CN201410392098A CN105001213B CN 105001213 B CN105001213 B CN 105001213B CN 201410392098 A CN201410392098 A CN 201410392098A CN 105001213 B CN105001213 B CN 105001213B
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- solvent
- following
- steps
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 38
- 229930182470 glycoside Natural products 0.000 title claims abstract description 24
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 17
- 150000001875 compounds Chemical class 0.000 claims abstract description 189
- 238000006243 chemical reaction Methods 0.000 claims abstract description 158
- 239000002904 solvent Substances 0.000 claims abstract description 113
- 238000000034 method Methods 0.000 claims abstract description 59
- 230000006196 deacetylation Effects 0.000 claims abstract description 18
- 238000003381 deacetylation reaction Methods 0.000 claims abstract description 18
- 125000006239 protecting group Chemical group 0.000 claims abstract description 18
- 150000003839 salts Chemical class 0.000 claims abstract description 16
- 239000003513 alkali Substances 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 12
- 230000009471 action Effects 0.000 claims abstract description 11
- 229930182478 glucoside Natural products 0.000 claims abstract description 9
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims abstract description 6
- 238000006751 Mitsunobu reaction Methods 0.000 claims abstract description 4
- 102000000070 Sodium-Glucose Transport Proteins Human genes 0.000 claims abstract 3
- 108010080361 Sodium-Glucose Transport Proteins Proteins 0.000 claims abstract 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 129
- 125000000217 alkyl group Chemical group 0.000 claims description 27
- 229910052799 carbon Inorganic materials 0.000 claims description 27
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 claims description 26
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 claims description 24
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 22
- 239000003814 drug Substances 0.000 claims description 21
- 229910052736 halogen Inorganic materials 0.000 claims description 16
- 150000002367 halogens Chemical class 0.000 claims description 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 15
- 229940124597 therapeutic agent Drugs 0.000 claims description 14
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 12
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 239000000460 chlorine Substances 0.000 claims description 9
- 229910052801 chlorine Inorganic materials 0.000 claims description 9
- 229910052731 fluorine Inorganic materials 0.000 claims description 9
- 238000006722 reduction reaction Methods 0.000 claims description 8
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052794 bromium Inorganic materials 0.000 claims description 7
- 206010012601 diabetes mellitus Diseases 0.000 claims description 7
- 229910052740 iodine Chemical group 0.000 claims description 7
- 239000011630 iodine Chemical group 0.000 claims description 7
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 6
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 229910052744 lithium Inorganic materials 0.000 claims description 5
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 5
- 125000001246 bromo group Chemical group Br* 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 230000001404 mediated effect Effects 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- 206010020772 Hypertension Diseases 0.000 claims description 3
- 208000008589 Obesity Diseases 0.000 claims description 3
- 235000020824 obesity Nutrition 0.000 claims description 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 229940121377 sodium-glucose co-transporter inhibitor Drugs 0.000 claims 1
- 239000000651 prodrug Substances 0.000 abstract description 8
- 229940002612 prodrug Drugs 0.000 abstract description 8
- 239000003112 inhibitor Substances 0.000 abstract description 3
- 239000002671 adjuvant Substances 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 207
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 108
- 239000000243 solution Substances 0.000 description 81
- -1 heterocycloalkyloxy Chemical group 0.000 description 73
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 68
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical group [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 66
- 238000005160 1H NMR spectroscopy Methods 0.000 description 62
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 62
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 56
- 229910001868 water Inorganic materials 0.000 description 53
- 230000015572 biosynthetic process Effects 0.000 description 44
- 238000003786 synthesis reaction Methods 0.000 description 44
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 42
- 239000012074 organic phase Substances 0.000 description 34
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 33
- 239000003208 petroleum Substances 0.000 description 31
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 30
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 30
- 238000010898 silica gel chromatography Methods 0.000 description 29
- 239000007787 solid Substances 0.000 description 29
- 239000000203 mixture Substances 0.000 description 28
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 26
- 239000010410 layer Substances 0.000 description 26
- 239000012043 crude product Substances 0.000 description 25
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 24
- 238000004458 analytical method Methods 0.000 description 23
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 23
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 21
- 238000002390 rotary evaporation Methods 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 19
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- 125000003118 aryl group Chemical group 0.000 description 18
- 229920006395 saturated elastomer Polymers 0.000 description 18
- 125000000753 cycloalkyl group Chemical group 0.000 description 17
- 239000011734 sodium Substances 0.000 description 17
- 239000003921 oil Substances 0.000 description 16
- 150000003254 radicals Chemical class 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 125000003545 alkoxy group Chemical group 0.000 description 15
- 125000001072 heteroaryl group Chemical group 0.000 description 15
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 14
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 13
- 125000004432 carbon atom Chemical group C* 0.000 description 13
- 238000004821 distillation Methods 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 125000002619 bicyclic group Chemical group 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 235000002639 sodium chloride Nutrition 0.000 description 12
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
- 239000008103 glucose Substances 0.000 description 11
- 210000002700 urine Anatomy 0.000 description 11
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical group O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 10
- 230000014759 maintenance of location Effects 0.000 description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 10
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 235000017557 sodium bicarbonate Nutrition 0.000 description 9
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 8
- 125000004438 haloalkoxy group Chemical group 0.000 description 8
- 125000005842 heteroatom Chemical group 0.000 description 8
- 229910052739 hydrogen Inorganic materials 0.000 description 8
- 239000012046 mixed solvent Substances 0.000 description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 238000010791 quenching Methods 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- IFZLNUZUEFXQRL-CYDVYFGRSA-N O1C(CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2C)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2C)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 IFZLNUZUEFXQRL-CYDVYFGRSA-N 0.000 description 7
- 229960001713 canagliflozin Drugs 0.000 description 7
- VHOFTEAWFCUTOS-TUGBYPPCSA-N canagliflozin hydrate Chemical compound O.CC1=CC=C([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C=C1CC(S1)=CC=C1C1=CC=C(F)C=C1.CC1=CC=C([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C=C1CC(S1)=CC=C1C1=CC=C(F)C=C1 VHOFTEAWFCUTOS-TUGBYPPCSA-N 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 125000002950 monocyclic group Chemical group 0.000 description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 238000001953 recrystallisation Methods 0.000 description 7
- 239000012279 sodium borohydride Substances 0.000 description 7
- 229910000033 sodium borohydride Inorganic materials 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 6
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 6
- 235000019270 ammonium chloride Nutrition 0.000 description 6
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 6
- 239000012230 colorless oil Substances 0.000 description 6
- 125000004122 cyclic group Chemical group 0.000 description 6
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 229910001629 magnesium chloride Inorganic materials 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- DPIALHFJIMHDAS-QYENANPWSA-N (2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-(2,3-dihydro-1-benzofuran-2-ylmethoxy)phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2 DPIALHFJIMHDAS-QYENANPWSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 5
- AYQMOLAIBRTRNL-DFLSAPQXSA-N O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2Cl)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2Cl)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 AYQMOLAIBRTRNL-DFLSAPQXSA-N 0.000 description 5
- 229940123518 Sodium/glucose cotransporter 2 inhibitor Drugs 0.000 description 5
- 125000003282 alkyl amino group Chemical group 0.000 description 5
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 5
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000001569 carbon dioxide Substances 0.000 description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 239000001103 potassium chloride Substances 0.000 description 5
- 235000011164 potassium chloride Nutrition 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 229910052717 sulfur Inorganic materials 0.000 description 5
- 230000002194 synthesizing effect Effects 0.000 description 5
- QYFBYHXEEODTMX-QMMMGPOBSA-N (2S)-2-(bromomethyl)-2,3-dihydro-1-benzofuran Chemical compound BrC[C@H]1OC2=C(C1)C=CC=C2 QYFBYHXEEODTMX-QMMMGPOBSA-N 0.000 description 4
- CJBNUOVCABHNLY-NSDXNHJYSA-N (2S,3R,4R,5S,6S)-2-[4-chloro-3-[[4-[(7-fluoro-2,3-dihydro-1-benzofuran-2-yl)methoxy]phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2F CJBNUOVCABHNLY-NSDXNHJYSA-N 0.000 description 4
- SSZOCHFYWWVSAI-UHFFFAOYSA-N 1-bromo-2-ethenylbenzene Chemical compound BrC1=CC=CC=C1C=C SSZOCHFYWWVSAI-UHFFFAOYSA-N 0.000 description 4
- RRUIKDIGARKZIA-UHFFFAOYSA-N 3-fluoro-2-prop-2-enylphenol Chemical compound OC1=CC=CC(F)=C1CC=C RRUIKDIGARKZIA-UHFFFAOYSA-N 0.000 description 4
- WUNQTXVVERFOSK-UHFFFAOYSA-N 5-fluoro-2-prop-2-enylphenol Chemical compound OC1=CC(F)=CC=C1CC=C WUNQTXVVERFOSK-UHFFFAOYSA-N 0.000 description 4
- VLQIGOKMXCJNAM-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4F)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4F)C=C2)C=1)Cl VLQIGOKMXCJNAM-UHFFFAOYSA-N 0.000 description 4
- BLKGHTVOWGHABE-KGFFULNXSA-N C1(OCC2=CC=CC=C12)COC1=CC=C(CC=2C=C(C=CC=2C)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound C1(OCC2=CC=CC=C12)COC1=CC=C(CC=2C=C(C=CC=2C)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 BLKGHTVOWGHABE-KGFFULNXSA-N 0.000 description 4
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 4
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 4
- KTGWASGADVZXKH-WGWDPUIZSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OCC2=CC=CC=C12 Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OCC2=CC=CC=C12 KTGWASGADVZXKH-WGWDPUIZSA-N 0.000 description 4
- DPIALHFJIMHDAS-RUPQSZEGSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@@H]1OC2=C(C1)C=CC=C2 Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@@H]1OC2=C(C1)C=CC=C2 DPIALHFJIMHDAS-RUPQSZEGSA-N 0.000 description 4
- DPIALHFJIMHDAS-RIVXRUHVSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@H]1OC2=C(C1)C=CC=C2 Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@H]1OC2=C(C1)C=CC=C2 DPIALHFJIMHDAS-RIVXRUHVSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 4
- IFZLNUZUEFXQRL-VQYGVQKLSA-N O1[C@@H](CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2C)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1[C@@H](CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2C)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 IFZLNUZUEFXQRL-VQYGVQKLSA-N 0.000 description 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 4
- 229910000024 caesium carbonate Inorganic materials 0.000 description 4
- 150000001721 carbon Chemical group 0.000 description 4
- DCFKHNIGBAHNSS-UHFFFAOYSA-N chloro(triethyl)silane Chemical compound CC[Si](Cl)(CC)CC DCFKHNIGBAHNSS-UHFFFAOYSA-N 0.000 description 4
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 4
- 125000005112 cycloalkylalkoxy group Chemical group 0.000 description 4
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 4
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 4
- 238000001308 synthesis method Methods 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- XBPDGDITBHGBNK-MRXNPFEDSA-N (2R)-1-(2-methoxyphenyl)-3-phenylmethoxypropan-2-ol Chemical compound C(C1=CC=CC=C1)OC[C@@H](CC1=C(C=CC=C1)OC)O XBPDGDITBHGBNK-MRXNPFEDSA-N 0.000 description 3
- KIMJBSWICNBTOJ-UHFFFAOYSA-N (3,3-dimethyl-1h-2-benzofuran-1-yl)methanol Chemical compound C1=CC=C2C(C)(C)OC(CO)C2=C1 KIMJBSWICNBTOJ-UHFFFAOYSA-N 0.000 description 3
- OEURLNJEQCLGPS-UHFFFAOYSA-N (5-bromo-2-chlorophenyl)-(4-ethoxyphenyl)methanone Chemical compound C1=CC(OCC)=CC=C1C(=O)C1=CC(Br)=CC=C1Cl OEURLNJEQCLGPS-UHFFFAOYSA-N 0.000 description 3
- LVILQFKAGQFQEK-UHFFFAOYSA-N (5-bromo-2-chlorophenyl)-(4-fluorophenyl)methanone Chemical compound C1=CC(F)=CC=C1C(=O)C1=CC(Br)=CC=C1Cl LVILQFKAGQFQEK-UHFFFAOYSA-N 0.000 description 3
- AKVQTDXFHZCUQD-UHFFFAOYSA-N (5-bromo-2-methoxyphenyl)-(4-fluorophenyl)methanone Chemical compound COC1=CC=C(Br)C=C1C(=O)C1=CC=C(F)C=C1 AKVQTDXFHZCUQD-UHFFFAOYSA-N 0.000 description 3
- VFXRFXAEZVQAHB-UHFFFAOYSA-N (5-fluoro-1-benzofuran-2-yl)methanol Chemical compound FC1=CC=C2OC(CO)=CC2=C1 VFXRFXAEZVQAHB-UHFFFAOYSA-N 0.000 description 3
- UWOCHNNRMCCPTF-UHFFFAOYSA-N (7-fluoro-2,3-dihydro-1-benzofuran-2-yl)methanol Chemical compound C1=CC(F)=C2OC(CO)CC2=C1 UWOCHNNRMCCPTF-UHFFFAOYSA-N 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
- OKTWLGWQEYGNBA-UHFFFAOYSA-N 1,3-dihydro-2-benzofuran-1-ylmethanol Chemical compound C1=CC=C2C(CO)OCC2=C1 OKTWLGWQEYGNBA-UHFFFAOYSA-N 0.000 description 3
- KKLSEIIDJBCSRK-UHFFFAOYSA-N 1-(chloromethyl)-2-ethenylbenzene Chemical compound ClCC1=CC=CC=C1C=C KKLSEIIDJBCSRK-UHFFFAOYSA-N 0.000 description 3
- HSOMHPHYGAQRTF-UHFFFAOYSA-N 1-benzofuran-2-ylmethanol Chemical class C1=CC=C2OC(CO)=CC2=C1 HSOMHPHYGAQRTF-UHFFFAOYSA-N 0.000 description 3
- MABBMHBZKPIFFV-UHFFFAOYSA-N 1-fluoro-2-prop-2-enoxybenzene Chemical compound FC1=CC=CC=C1OCC=C MABBMHBZKPIFFV-UHFFFAOYSA-N 0.000 description 3
- WTUUABQVRKOWKA-UHFFFAOYSA-N 1-fluoro-3-prop-2-enoxybenzene Chemical compound FC1=CC=CC(OCC=C)=C1 WTUUABQVRKOWKA-UHFFFAOYSA-N 0.000 description 3
- WDZLZKSUBSXWID-UHFFFAOYSA-N 2,3-dihydro-1-benzofuran-2-ol Chemical compound C1=CC=C2OC(O)CC2=C1 WDZLZKSUBSXWID-UHFFFAOYSA-N 0.000 description 3
- ZJMQZZXXIOGDIO-UHFFFAOYSA-N 2-(2,3-dihydro-1-benzofuran-2-yl)ethanol Chemical compound C1=CC=C2OC(CCO)CC2=C1 ZJMQZZXXIOGDIO-UHFFFAOYSA-N 0.000 description 3
- ZHYZZBGVWDYSEW-UHFFFAOYSA-N 2-(2-bromophenyl)oxirane Chemical compound BrC1=CC=CC=C1C1OC1 ZHYZZBGVWDYSEW-UHFFFAOYSA-N 0.000 description 3
- BYACWLJXEJASBO-UHFFFAOYSA-N 2-(3-fluorophenyl)oxane Chemical compound FC=1C=C(C=CC=1)C1OCCCC1 BYACWLJXEJASBO-UHFFFAOYSA-N 0.000 description 3
- IWFBKDZCZVDZRT-UHFFFAOYSA-N 2-(chloromethyl)-5-fluoro-1-benzofuran Chemical compound FC1=CC=C2OC(CCl)=CC2=C1 IWFBKDZCZVDZRT-UHFFFAOYSA-N 0.000 description 3
- ADDZHRRCUWNSCS-UHFFFAOYSA-N 2-Benzofurancarboxaldehyde Chemical compound C1=CC=C2OC(C=O)=CC2=C1 ADDZHRRCUWNSCS-UHFFFAOYSA-N 0.000 description 3
- DHXICAQGITWFAS-VIFPVBQESA-N 2-[(3R)-3-bromo-3-hydroxypropyl]phenol Chemical compound Br[C@H](CCC1=C(C=CC=C1)O)O DHXICAQGITWFAS-VIFPVBQESA-N 0.000 description 3
- DHEJIZSVHGOKMJ-UHFFFAOYSA-N 2-ethenylbenzaldehyde Chemical compound C=CC1=CC=CC=C1C=O DHEJIZSVHGOKMJ-UHFFFAOYSA-N 0.000 description 3
- YKZMHGAKPDCTCH-UHFFFAOYSA-N 2-fluoro-6-(oxan-2-yloxy)benzaldehyde Chemical compound FC1=CC=CC(OC2OCCCC2)=C1C=O YKZMHGAKPDCTCH-UHFFFAOYSA-N 0.000 description 3
- FZIBGCDUHZBOLA-UHFFFAOYSA-N 2-fluoro-6-hydroxybenzaldehyde Chemical compound OC1=CC=CC(F)=C1C=O FZIBGCDUHZBOLA-UHFFFAOYSA-N 0.000 description 3
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 3
- SJTBRFHBXDZMPS-UHFFFAOYSA-N 3-fluorophenol Chemical compound OC1=CC=CC(F)=C1 SJTBRFHBXDZMPS-UHFFFAOYSA-N 0.000 description 3
- ZUNCHZBITMUSRD-UHFFFAOYSA-N 4-bromo-1-chloro-2-[(4-ethoxyphenyl)methyl]benzene Chemical compound C1=CC(OCC)=CC=C1CC1=CC(Br)=CC=C1Cl ZUNCHZBITMUSRD-UHFFFAOYSA-N 0.000 description 3
- JFDUXZIRWBYBAQ-UHFFFAOYSA-N 5-bromo-2-methoxybenzoic acid Chemical compound COC1=CC=C(Br)C=C1C(O)=O JFDUXZIRWBYBAQ-UHFFFAOYSA-N 0.000 description 3
- FDUBQNUDZOGOFE-UHFFFAOYSA-N 5-fluoro-2-hydroxybenzaldehyde Chemical compound OC1=CC=C(F)C=C1C=O FDUBQNUDZOGOFE-UHFFFAOYSA-N 0.000 description 3
- XLEBMLLEWBPUAT-UHFFFAOYSA-N 7-fluoro-2,3-dihydro-1-benzofuran Chemical compound FC1=CC=CC2=C1OCC2 XLEBMLLEWBPUAT-UHFFFAOYSA-N 0.000 description 3
- NJXLGWSKFGQCQM-UHFFFAOYSA-N BrC1=CC(=C(C#N)C=C1)C(O)C1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2 Chemical compound BrC1=CC(=C(C#N)C=C1)C(O)C1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2 NJXLGWSKFGQCQM-UHFFFAOYSA-N 0.000 description 3
- JZUIPNJQQBHLQR-UHFFFAOYSA-N BrC1=CC(=C(C#N)C=C1)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2 Chemical compound BrC1=CC(=C(C#N)C=C1)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2 JZUIPNJQQBHLQR-UHFFFAOYSA-N 0.000 description 3
- BHRILQRVZAKUJL-UHFFFAOYSA-N BrC=1C=CC(=C(C=1)C(=O)C1=CC=C(C=C1)F)O Chemical compound BrC=1C=CC(=C(C=1)C(=O)C1=CC=C(C=C1)F)O BHRILQRVZAKUJL-UHFFFAOYSA-N 0.000 description 3
- IJLICWIHSZYBFU-UHFFFAOYSA-N BrC=1C=CC(=C(C=1)C(=O)C1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2F)Cl Chemical compound BrC=1C=CC(=C(C=1)C(=O)C1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2F)Cl IJLICWIHSZYBFU-UHFFFAOYSA-N 0.000 description 3
- BIGVVTGYXZQHKR-UHFFFAOYSA-N BrCCC1OC2=C(C1)C=CC=C2 Chemical compound BrCCC1OC2=C(C1)C=CC=C2 BIGVVTGYXZQHKR-UHFFFAOYSA-N 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- CJBNUOVCABHNLY-FMHUMOTFSA-N ClC1=C(C=C(C=C1)C1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2F Chemical compound ClC1=C(C=C(C=C1)C1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2F CJBNUOVCABHNLY-FMHUMOTFSA-N 0.000 description 3
- 229940126062 Compound A Drugs 0.000 description 3
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 3
- OKTWLGWQEYGNBA-SECBINFHSA-N OC[C@H]1OCc2ccccc12 Chemical compound OC[C@H]1OCc2ccccc12 OKTWLGWQEYGNBA-SECBINFHSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ITMGMSZDAOAVNO-QMMMGPOBSA-N [(2s)-2,3-dihydro-1-benzofuran-2-yl]methanol Chemical compound C1=CC=C2O[C@H](CO)CC2=C1 ITMGMSZDAOAVNO-QMMMGPOBSA-N 0.000 description 3
- OKTWLGWQEYGNBA-VIFPVBQESA-N [C@H]1(OCC2=CC=CC=C12)CO Chemical compound [C@H]1(OCC2=CC=CC=C12)CO OKTWLGWQEYGNBA-VIFPVBQESA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 125000003342 alkenyl group Chemical group 0.000 description 3
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 3
- 239000003472 antidiabetic agent Substances 0.000 description 3
- DIHWNRNXRGICRQ-UHFFFAOYSA-N benzyl but-3-enoate Chemical compound C=CCC(=O)OCC1=CC=CC=C1 DIHWNRNXRGICRQ-UHFFFAOYSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 125000000000 cycloalkoxy group Chemical group 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 229960003345 empagliflozin Drugs 0.000 description 3
- OBWASQILIWPZMG-QZMOQZSNSA-N empagliflozin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=CC=C(Cl)C(CC=2C=CC(O[C@@H]3COCC3)=CC=2)=C1 OBWASQILIWPZMG-QZMOQZSNSA-N 0.000 description 3
- RBQUPHUYCPBKSF-UHFFFAOYSA-N ethyl 5-fluoro-1-benzofuran-2-carboxylate Chemical compound FC1=CC=C2OC(C(=O)OCC)=CC2=C1 RBQUPHUYCPBKSF-UHFFFAOYSA-N 0.000 description 3
- 239000012065 filter cake Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical group [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 3
- DXYFFDHUTOBVEK-UHFFFAOYSA-N methanol;styrene Chemical compound OC.C=CC1=CC=CC=C1 DXYFFDHUTOBVEK-UHFFFAOYSA-N 0.000 description 3
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 3
- 125000006578 monocyclic heterocycloalkyl group Chemical group 0.000 description 3
- 125000006574 non-aromatic ring group Chemical group 0.000 description 3
- 239000001301 oxygen Chemical group 0.000 description 3
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 3
- 238000004808 supercritical fluid chromatography Methods 0.000 description 3
- ZGYICYBLPGRURT-UHFFFAOYSA-N tri(propan-2-yl)silicon Chemical compound CC(C)[Si](C(C)C)C(C)C ZGYICYBLPGRURT-UHFFFAOYSA-N 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- QYFBYHXEEODTMX-MRVPVSSYSA-N (2r)-2-(bromomethyl)-2,3-dihydro-1-benzofuran Chemical compound C1=CC=C2O[C@@H](CBr)CC2=C1 QYFBYHXEEODTMX-MRVPVSSYSA-N 0.000 description 2
- LDDMACCNBZAMSG-BDVNFPICSA-N (2r,3r,4s,5r)-3,4,5,6-tetrahydroxy-2-(methylamino)hexanal Chemical compound CN[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO LDDMACCNBZAMSG-BDVNFPICSA-N 0.000 description 2
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- NNQDMQVWOWCVEM-UHFFFAOYSA-N 1-bromoprop-1-ene Chemical compound CC=CBr NNQDMQVWOWCVEM-UHFFFAOYSA-N 0.000 description 2
- LSGCBNJHZGJEEJ-UHFFFAOYSA-N 2-(chloromethyl)-1-benzofuran Chemical compound C1=CC=C2OC(CCl)=CC2=C1 LSGCBNJHZGJEEJ-UHFFFAOYSA-N 0.000 description 2
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- YUCBLVFHJWOYDN-PPIALRKJSA-N 4-[(r)-[(2r,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methoxy]-1-[(r)-[(2r,4r,5s)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methoxy]phthalazine Chemical compound C1=C(OC)C=C2C([C@@H](OC=3C4=CC=CC=C4C(O[C@@H]([C@@H]4N5CC[C@@H]([C@@H](C5)CC)C4)C=4C5=CC(OC)=CC=C5N=CC=4)=NN=3)[C@H]3C[C@@H]4CCN3C[C@@H]4CC)=CC=NC2=C1 YUCBLVFHJWOYDN-PPIALRKJSA-N 0.000 description 2
- GBJJCODOZGPTBC-UHFFFAOYSA-N 4-fluoro-2-hydroxybenzaldehyde Chemical compound OC1=CC(F)=CC=C1C=O GBJJCODOZGPTBC-UHFFFAOYSA-N 0.000 description 2
- 125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 2
- FGERXQWKKIVFQG-UHFFFAOYSA-N 5-bromo-2-chlorobenzoic acid Chemical compound OC(=O)C1=CC(Br)=CC=C1Cl FGERXQWKKIVFQG-UHFFFAOYSA-N 0.000 description 2
- HELBBGLIOALLAF-UHFFFAOYSA-N 5-bromo-2-cyanobenzoic acid Chemical compound OC(=O)C1=CC(Br)=CC=C1C#N HELBBGLIOALLAF-UHFFFAOYSA-N 0.000 description 2
- KRNSYSYRLQDHDK-UHFFFAOYSA-N 6,7-dihydro-5h-cyclopenta[b]pyridine Chemical compound C1=CN=C2CCCC2=C1 KRNSYSYRLQDHDK-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- XVGIBYTWUNKGFC-SNVBAGLBSA-N CC=1C=C2CO[C@@H](C2=CC=1)CO Chemical compound CC=1C=C2CO[C@@H](C2=CC=1)CO XVGIBYTWUNKGFC-SNVBAGLBSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- ZYPBQGOGPKQPFM-TWQRTPDCSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC(=C(C=C1)OCC1OC2=C(C1)C=CC=C2)F Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC(=C(C=C1)OCC1OC2=C(C1)C=CC=C2)F ZYPBQGOGPKQPFM-TWQRTPDCSA-N 0.000 description 2
- XYQLRDQDWFTIEY-KGFFULNXSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC(C2=CC=CC=C12)(C)C Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC(C2=CC=CC=C12)(C)C XYQLRDQDWFTIEY-KGFFULNXSA-N 0.000 description 2
- DBRFXVYVLMFFSQ-TWQRTPDCSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C(=CC=C2)F Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C(=CC=C2)F DBRFXVYVLMFFSQ-TWQRTPDCSA-N 0.000 description 2
- ZKCQEPKJMTVUPT-AQCDROMSSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=C(C=C2)C Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=C(C=C2)C ZKCQEPKJMTVUPT-AQCDROMSSA-N 0.000 description 2
- YLUOFFVBNMGJSO-QYENANPWSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=C(C=C2)F Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=C(C=C2)F YLUOFFVBNMGJSO-QYENANPWSA-N 0.000 description 2
- PVDJPDFLWJGBIA-QYENANPWSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC(=C2)F Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC(=C2)F PVDJPDFLWJGBIA-QYENANPWSA-N 0.000 description 2
- RBEJDGYWSLUYEX-AQCDROMSSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCCC1OC2=C(C1)C=CC=C2 Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OCCC1OC2=C(C1)C=CC=C2 RBEJDGYWSLUYEX-AQCDROMSSA-N 0.000 description 2
- KTGWASGADVZXKH-JABWBWSPSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@@H]1OCC2=CC=CC=C12 Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@@H]1OCC2=CC=CC=C12 KTGWASGADVZXKH-JABWBWSPSA-N 0.000 description 2
- MHDQPSWZICUHJJ-CJSXUKLZSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@H]1OCC2=CC(=CC=C12)C Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@H]1OCC2=CC(=CC=C12)C MHDQPSWZICUHJJ-CJSXUKLZSA-N 0.000 description 2
- PGBNOKIUOPBGKO-GTMDKHCLSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@H]1OCC2=CC(=CC=C12)F Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@H]1OCC2=CC(=CC=C12)F PGBNOKIUOPBGKO-GTMDKHCLSA-N 0.000 description 2
- KTGWASGADVZXKH-GTMDKHCLSA-N ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@H]1OCC2=CC=CC=C12 Chemical compound ClC1=C(C=C(C=C1)[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)CC1=CC=C(C=C1)OC[C@H]1OCC2=CC=CC=C12 KTGWASGADVZXKH-GTMDKHCLSA-N 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- OBWASQILIWPZMG-UHFFFAOYSA-N Empagliflozin Chemical compound OC1C(O)C(O)C(CO)OC1C1=CC=C(Cl)C(CC=2C=CC(OC3COCC3)=CC=2)=C1 OBWASQILIWPZMG-UHFFFAOYSA-N 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- VFLMFIMNNIHXQU-SECBINFHSA-N FC=1C=C2CO[C@@H](C2=CC=1)CO Chemical compound FC=1C=C2CO[C@@H](C2=CC=1)CO VFLMFIMNNIHXQU-SECBINFHSA-N 0.000 description 2
- 108091052347 Glucose transporter family Proteins 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 241000208125 Nicotiana Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- LWQWDNDVPLPJCY-DFLSAPQXSA-N O1C(=CC2=C1C=CC=C2)COC1=C(C=C(CC=2C=C(C=CC=2Cl)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1)F Chemical compound O1C(=CC2=C1C=CC=C2)COC1=C(C=C(CC=2C=C(C=CC=2Cl)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1)F LWQWDNDVPLPJCY-DFLSAPQXSA-N 0.000 description 2
- IPBHNTPOJRNPCZ-RQKPWJHBSA-N O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC2=C(C#N)C=CC(=C2)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC2=C(C#N)C=CC(=C2)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 IPBHNTPOJRNPCZ-RQKPWJHBSA-N 0.000 description 2
- NIKWHNYNSIKYHY-DFLSAPQXSA-N O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 NIKWHNYNSIKYHY-DFLSAPQXSA-N 0.000 description 2
- LYZBNSNBRSKCKG-DFLSAPQXSA-N O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2F)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2F)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 LYZBNSNBRSKCKG-DFLSAPQXSA-N 0.000 description 2
- VYPKMXZMMOSMLR-RQKPWJHBSA-N O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2OC)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2OC)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 VYPKMXZMMOSMLR-RQKPWJHBSA-N 0.000 description 2
- PUWUVKYKRLFQMR-CYDVYFGRSA-N O1C(CC2=C1C=CC=C2)COC1=CC=C(CC2=C(C#N)C=CC(=C2)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(CC2=C1C=CC=C2)COC1=CC=C(CC2=C(C#N)C=CC(=C2)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 PUWUVKYKRLFQMR-CYDVYFGRSA-N 0.000 description 2
- XNNQAARVCUYAKW-RMFGLVLUSA-N O1C(CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 XNNQAARVCUYAKW-RMFGLVLUSA-N 0.000 description 2
- VYLYNQGAEQUOKU-QYENANPWSA-N O1C(CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2F)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2F)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 VYLYNQGAEQUOKU-QYENANPWSA-N 0.000 description 2
- GBOINAFCKBFJMU-AQCDROMSSA-N O1C(CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2OC)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2OC)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 GBOINAFCKBFJMU-AQCDROMSSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 208000021017 Weight Gain Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000004296 chiral HPLC Methods 0.000 description 2
- KQIADDMXRMTWHZ-UHFFFAOYSA-N chloro-tri(propan-2-yl)silane Chemical compound CC(C)[Si](Cl)(C(C)C)C(C)C KQIADDMXRMTWHZ-UHFFFAOYSA-N 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 2
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- QMMFVYPAHWMCMS-UHFFFAOYSA-N dimethyl monosulfide Natural products CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000010030 glucose lowering effect Effects 0.000 description 2
- 125000001188 haloalkyl group Chemical group 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- PYLWMHQQBFSUBP-UHFFFAOYSA-N monofluorobenzene Chemical compound FC1=CC=CC=C1 PYLWMHQQBFSUBP-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 2
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical class [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000011593 sulfur Chemical group 0.000 description 2
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 2
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 2
- 229930192474 thiophene Natural products 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- FIQMHBFVRAXMOP-UHFFFAOYSA-N triphenylphosphane oxide Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=O)C1=CC=CC=C1 FIQMHBFVRAXMOP-UHFFFAOYSA-N 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- UXOFRFPVWFJROK-UHFFFAOYSA-N (2-ethenylphenyl)methanol Chemical compound OCC1=CC=CC=C1C=C UXOFRFPVWFJROK-UHFFFAOYSA-N 0.000 description 1
- QNYBOILAKBSWFG-JTQLQIEISA-N (2r)-2-(phenylmethoxymethyl)oxirane Chemical compound C([C@@H]1OC1)OCC1=CC=CC=C1 QNYBOILAKBSWFG-JTQLQIEISA-N 0.000 description 1
- QNYBOILAKBSWFG-SNVBAGLBSA-N (2s)-2-(phenylmethoxymethyl)oxirane Chemical compound C([C@H]1OC1)OCC1=CC=CC=C1 QNYBOILAKBSWFG-SNVBAGLBSA-N 0.000 description 1
- QLWGPEHYNFONNA-UHFFFAOYSA-N (3-bromophenyl)-(4-fluorophenyl)methanone Chemical compound C1=CC(F)=CC=C1C(=O)C1=CC=CC(Br)=C1 QLWGPEHYNFONNA-UHFFFAOYSA-N 0.000 description 1
- GZHRFQYLSXKVMB-UHFFFAOYSA-N (5-bromo-2-methylphenyl)-(4-fluorophenyl)methanone Chemical compound CC1=CC=C(Br)C=C1C(=O)C1=CC=C(F)C=C1 GZHRFQYLSXKVMB-UHFFFAOYSA-N 0.000 description 1
- 125000006584 (C3-C10) heterocycloalkyl group Chemical group 0.000 description 1
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 description 1
- DQXKOHDUMJLXKH-PHEQNACWSA-N (e)-n-[2-[2-[[(e)-oct-2-enoyl]amino]ethyldisulfanyl]ethyl]oct-2-enamide Chemical compound CCCCC\C=C\C(=O)NCCSSCCNC(=O)\C=C\CCCCC DQXKOHDUMJLXKH-PHEQNACWSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 1
- HTDQSWDEWGSAMN-UHFFFAOYSA-N 1-bromo-2-methoxybenzene Chemical compound COC1=CC=CC=C1Br HTDQSWDEWGSAMN-UHFFFAOYSA-N 0.000 description 1
- NZKWIAVSCANBMU-UHFFFAOYSA-N 1-bromo-3-[(4-ethoxyphenyl)methyl]benzene Chemical compound C1=CC(OCC)=CC=C1CC1=CC=CC(Br)=C1 NZKWIAVSCANBMU-UHFFFAOYSA-N 0.000 description 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- SFFUEHODRAXXIA-UHFFFAOYSA-N 2,2,2-trifluoroacetonitrile Chemical compound FC(F)(F)C#N SFFUEHODRAXXIA-UHFFFAOYSA-N 0.000 description 1
- ITMGMSZDAOAVNO-UHFFFAOYSA-N 2,3-dihydro-1-benzofuran-2-ylmethanol Chemical compound C1=CC=C2OC(CO)CC2=C1 ITMGMSZDAOAVNO-UHFFFAOYSA-N 0.000 description 1
- GNENVASJJIUNER-UHFFFAOYSA-N 2,4,6-tricyclohexyloxy-1,3,5,2,4,6-trioxatriborinane Chemical compound C1CCCCC1OB1OB(OC2CCCCC2)OB(OC2CCCCC2)O1 GNENVASJJIUNER-UHFFFAOYSA-N 0.000 description 1
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-Lutidine Substances CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 1
- HGLRGLPUTGCWQB-UHFFFAOYSA-N 2-(2-ethenylphenyl)ethanol Chemical compound OCCC1=CC=CC=C1C=C HGLRGLPUTGCWQB-UHFFFAOYSA-N 0.000 description 1
- MFHFWRBXPQDZSA-UHFFFAOYSA-N 2-(4-bromophenyl)acetonitrile Chemical compound BrC1=CC=C(CC#N)C=C1 MFHFWRBXPQDZSA-UHFFFAOYSA-N 0.000 description 1
- WWPKCWFXTQSXKX-UHFFFAOYSA-N 2-[[4-[(5-bromo-2-methoxyphenyl)methyl]phenyl]methyl]-1-benzofuran Chemical compound BrC=1C=CC(=C(CC2=CC=C(C=C2)CC=2OC3=C(C=2)C=CC=C3)C=1)OC WWPKCWFXTQSXKX-UHFFFAOYSA-N 0.000 description 1
- QIRNGVVZBINFMX-UHFFFAOYSA-N 2-allylphenol Chemical compound OC1=CC=CC=C1CC=C QIRNGVVZBINFMX-UHFFFAOYSA-N 0.000 description 1
- NDOPHXWIAZIXPR-UHFFFAOYSA-N 2-bromobenzaldehyde Chemical compound BrC1=CC=CC=C1C=O NDOPHXWIAZIXPR-UHFFFAOYSA-N 0.000 description 1
- HFHFGHLXUCOHLN-UHFFFAOYSA-N 2-fluorophenol Chemical compound OC1=CC=CC=C1F HFHFGHLXUCOHLN-UHFFFAOYSA-N 0.000 description 1
- PHXGVUCVCYAGQL-UHFFFAOYSA-N 3,4-dihydro-2h-1,4-benzoxazine Chemical compound C1=CC=C2NCCOC2=C1.C1=CC=C2NCCOC2=C1 PHXGVUCVCYAGQL-UHFFFAOYSA-N 0.000 description 1
- PHKYYUQQYARDIU-UHFFFAOYSA-N 3-methyl-9h-carbazole Chemical compound C1=CC=C2C3=CC(C)=CC=C3NC2=C1 PHKYYUQQYARDIU-UHFFFAOYSA-N 0.000 description 1
- BEYBTNQFCZVLQL-UHFFFAOYSA-N 4-bromo-2-[(4-ethoxyphenyl)methyl]-1-fluorobenzene Chemical compound C1=CC(OCC)=CC=C1CC1=CC(Br)=CC=C1F BEYBTNQFCZVLQL-UHFFFAOYSA-N 0.000 description 1
- MPOCPHMKKBYZMO-UHFFFAOYSA-N 4-bromo-2-[(4-ethoxyphenyl)methyl]-1-methylbenzene Chemical compound C1=CC(OCC)=CC=C1CC1=CC(Br)=CC=C1C MPOCPHMKKBYZMO-UHFFFAOYSA-N 0.000 description 1
- WJFJJYNKLXCHHX-UHFFFAOYSA-N 4-bromo-2-[(4-ethoxyphenyl)methyl]benzonitrile Chemical compound C1=CC(OCC)=CC=C1CC1=CC(Br)=CC=C1C#N WJFJJYNKLXCHHX-UHFFFAOYSA-N 0.000 description 1
- RHMPLDJJXGPMEX-UHFFFAOYSA-N 4-fluorophenol Chemical compound OC1=CC=C(F)C=C1 RHMPLDJJXGPMEX-UHFFFAOYSA-N 0.000 description 1
- IJIBRSFAXRFPPN-UHFFFAOYSA-N 5-bromo-2-methoxybenzaldehyde Chemical compound COC1=CC=C(Br)C=C1C=O IJIBRSFAXRFPPN-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- WCPFBDXSTATULX-UHFFFAOYSA-N BrC1=CC(=C(C#N)C=C1)C(C1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2)=O Chemical compound BrC1=CC(=C(C#N)C=C1)C(C1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2)=O WCPFBDXSTATULX-UHFFFAOYSA-N 0.000 description 1
- MEQVJPAXGJYBRP-UHFFFAOYSA-N BrC1=CC(=C(C=C1)Cl)CC1=CC(=C(C=C1)OC)F Chemical compound BrC1=CC(=C(C=C1)Cl)CC1=CC(=C(C=C1)OC)F MEQVJPAXGJYBRP-UHFFFAOYSA-N 0.000 description 1
- WBVUGMIGLDKZCG-UHFFFAOYSA-N BrC=1C=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4)C=C2)C=CC=1 Chemical compound BrC=1C=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4)C=C2)C=CC=1 WBVUGMIGLDKZCG-UHFFFAOYSA-N 0.000 description 1
- FGKLXDWIRXHPDM-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC(C4=CC=CC=C34)(C)C)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC(C4=CC=CC=C34)(C)C)C=C2)C=1)Cl FGKLXDWIRXHPDM-UHFFFAOYSA-N 0.000 description 1
- KEWCSGQGTMJEHR-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C(=CC=C4)F)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C(=CC=C4)F)C=C2)C=1)Cl KEWCSGQGTMJEHR-UHFFFAOYSA-N 0.000 description 1
- OEAQJQFNHMQDCC-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=C(C=C4)C)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=C(C=C4)C)C=C2)C=1)Cl OEAQJQFNHMQDCC-UHFFFAOYSA-N 0.000 description 1
- CYTSYAUVKCCCAF-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=C(C=C4)F)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=C(C=C4)F)C=C2)C=1)Cl CYTSYAUVKCCCAF-UHFFFAOYSA-N 0.000 description 1
- BWXMIBDLGJKSAK-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC(=C4)F)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC(=C4)F)C=C2)C=1)Cl BWXMIBDLGJKSAK-UHFFFAOYSA-N 0.000 description 1
- QJTBOEMYDKQCOM-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4)C=C2)C=1)C Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4)C=C2)C=1)C QJTBOEMYDKQCOM-UHFFFAOYSA-N 0.000 description 1
- SORWURQBSCSEJP-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4)C=C2)C=1)Cl SORWURQBSCSEJP-UHFFFAOYSA-N 0.000 description 1
- CATGOURPAQRYOR-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4)C=C2)C=1)OC Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OC4=C(C3)C=CC=C4)C=C2)C=1)OC CATGOURPAQRYOR-UHFFFAOYSA-N 0.000 description 1
- OMLBEQAVQZXNBE-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OCC4=CC=CC=C34)C=C2)C=1)C Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OCC4=CC=CC=C34)C=C2)C=1)C OMLBEQAVQZXNBE-UHFFFAOYSA-N 0.000 description 1
- MXFGXEDSHGDHMO-UHFFFAOYSA-N BrC=1C=CC(=C(CC2=CC=C(OCC3OCC4=CC=CC=C34)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OCC3OCC4=CC=CC=C34)C=C2)C=1)Cl MXFGXEDSHGDHMO-UHFFFAOYSA-N 0.000 description 1
- MXFGXEDSHGDHMO-QFIPXVFZSA-N BrC=1C=CC(=C(CC2=CC=C(OC[C@@H]3OCC4=CC=CC=C34)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OC[C@@H]3OCC4=CC=CC=C34)C=C2)C=1)Cl MXFGXEDSHGDHMO-QFIPXVFZSA-N 0.000 description 1
- QJTBOEMYDKQCOM-QFIPXVFZSA-N BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OC4=C(C3)C=CC=C4)C=C2)C=1)C Chemical compound BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OC4=C(C3)C=CC=C4)C=C2)C=1)C QJTBOEMYDKQCOM-QFIPXVFZSA-N 0.000 description 1
- SORWURQBSCSEJP-FQEVSTJZSA-N BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OC4=C(C3)C=CC=C4)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OC4=C(C3)C=CC=C4)C=C2)C=1)Cl SORWURQBSCSEJP-FQEVSTJZSA-N 0.000 description 1
- SAIGKYGQBCWHRO-HSZRJFAPSA-N BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OCC4=CC(=CC=C34)C)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OCC4=CC(=CC=C34)C)C=C2)C=1)Cl SAIGKYGQBCWHRO-HSZRJFAPSA-N 0.000 description 1
- JYDORGPQLIXHFE-JOCHJYFZSA-N BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OCC4=CC(=CC=C34)F)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OCC4=CC(=CC=C34)F)C=C2)C=1)Cl JYDORGPQLIXHFE-JOCHJYFZSA-N 0.000 description 1
- MXFGXEDSHGDHMO-JOCHJYFZSA-N BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OCC4=CC=CC=C34)C=C2)C=1)Cl Chemical compound BrC=1C=CC(=C(CC2=CC=C(OC[C@H]3OCC4=CC=CC=C34)C=C2)C=1)Cl MXFGXEDSHGDHMO-JOCHJYFZSA-N 0.000 description 1
- ASVYXWZOBCRSFB-UHFFFAOYSA-N C(C)S(=O)(O)=S.OCCN1CCNCC1 Chemical compound C(C)S(=O)(O)=S.OCCN1CCNCC1 ASVYXWZOBCRSFB-UHFFFAOYSA-N 0.000 description 1
- XTNGUQKDFGDXSJ-ZXGKGEBGSA-N Canagliflozin Chemical compound CC1=CC=C([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C=C1CC(S1)=CC=C1C1=CC=C(F)C=C1 XTNGUQKDFGDXSJ-ZXGKGEBGSA-N 0.000 description 1
- OKTJSMMVPCPJKN-NJFSPNSNSA-N Carbon-14 Chemical group [14C] OKTJSMMVPCPJKN-NJFSPNSNSA-N 0.000 description 1
- 241000167550 Centella Species 0.000 description 1
- VTGAJDMLNBVTRF-SJZQLPTNSA-N ClC1=C(C=C(C=C1)C1(O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)OC)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2F Chemical compound ClC1=C(C=C(C=C1)C1(O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)OC)CC1=CC=C(C=C1)OCC1OC2=C(C1)C=CC=C2F VTGAJDMLNBVTRF-SJZQLPTNSA-N 0.000 description 1
- JVZAZWKXHOJDCX-UHFFFAOYSA-N ClCC=1OC2=C(C=1)C(=CC=C2)F Chemical compound ClCC=1OC2=C(C=1)C(=CC=C2)F JVZAZWKXHOJDCX-UHFFFAOYSA-N 0.000 description 1
- FWMZQFQQEMRXLU-UHFFFAOYSA-N ClCC=1OC2=C(C=1)C=CC(=C2)F Chemical compound ClCC=1OC2=C(C=1)C=CC(=C2)F FWMZQFQQEMRXLU-UHFFFAOYSA-N 0.000 description 1
- IEHLSVIJVDOAKT-UHFFFAOYSA-N ClCC=1OC2=C(C=1)C=CC=C2F Chemical compound ClCC=1OC2=C(C=1)C=CC=C2F IEHLSVIJVDOAKT-UHFFFAOYSA-N 0.000 description 1
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- JVHXJTBJCFBINQ-ADAARDCZSA-N Dapagliflozin Chemical compound C1=CC(OCC)=CC=C1CC1=CC([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=CC=C1Cl JVHXJTBJCFBINQ-ADAARDCZSA-N 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 102000018711 Facilitative Glucose Transport Proteins Human genes 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 102000042092 Glucose transporter family Human genes 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- DBTDEFJAFBUGPP-UHFFFAOYSA-N Methanethial Chemical compound S=C DBTDEFJAFBUGPP-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- MEIZZXIIHFPBDY-RQKPWJHBSA-N O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2C)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 Chemical compound O1C(=CC2=C1C=CC=C2)COC1=CC=C(CC=2C=C(C=CC=2C)[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C1 MEIZZXIIHFPBDY-RQKPWJHBSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 240000003152 Rhus chinensis Species 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 229940101006 anhydrous sodium sulfite Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 150000004303 annulenes Chemical class 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 229940125708 antidiabetic agent Drugs 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 125000004069 aziridinyl group Chemical group 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- UMIVXZPTRXBADB-UHFFFAOYSA-N benzocyclobutene Chemical compound C1=CC=C2CCC2=C1 UMIVXZPTRXBADB-UHFFFAOYSA-N 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- ANUZKYYBDVLEEI-UHFFFAOYSA-N butane;hexane;lithium Chemical compound [Li]CCCC.CCCCCC ANUZKYYBDVLEEI-UHFFFAOYSA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical compound C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 description 1
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 229960003834 dapagliflozin Drugs 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 125000004431 deuterium atom Chemical group 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000005879 dioxolanyl group Chemical group 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 230000009229 glucose formation Effects 0.000 description 1
- 230000004190 glucose uptake Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- KRGUYSPPLXOXEJ-XBXARRHUSA-N methyl (E)-4-(2-hydroxyphenyl)but-2-enoate Chemical compound COC(=O)\C=C\CC1=CC=CC=C1O KRGUYSPPLXOXEJ-XBXARRHUSA-N 0.000 description 1
- YNIGPUJYUCFJOX-UHFFFAOYSA-N methyl 2-(2,3-dihydro-1-benzofuran-2-yl)acetate Chemical compound C1=CC=C2OC(CC(=O)OC)CC2=C1 YNIGPUJYUCFJOX-UHFFFAOYSA-N 0.000 description 1
- NTNUDYROPUKXNA-UHFFFAOYSA-N methyl 2-(triphenyl-$l^{5}-phosphanylidene)acetate Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC(=O)OC)C1=CC=CC=C1 NTNUDYROPUKXNA-UHFFFAOYSA-N 0.000 description 1
- YNIGPUJYUCFJOX-VIFPVBQESA-N methyl 2-[(2S)-2,3-dihydro-1-benzofuran-2-yl]acetate Chemical compound COC(=O)C[C@@H]1Cc2ccccc2O1 YNIGPUJYUCFJOX-VIFPVBQESA-N 0.000 description 1
- HOVAGTYPODGVJG-ZFYZTMLRSA-N methyl alpha-D-glucopyranoside Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-ZFYZTMLRSA-N 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- LSEFCHWGJNHZNT-UHFFFAOYSA-M methyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1 LSEFCHWGJNHZNT-UHFFFAOYSA-M 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012285 osmium tetroxide Substances 0.000 description 1
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- QVGXLLKOCUKJST-NJFSPNSNSA-N oxygen-18 atom Chemical group [18O] QVGXLLKOCUKJST-NJFSPNSNSA-N 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000011170 pharmaceutical development Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000030558 renal glucose absorption Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 229940001482 sodium sulfite Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000004192 tetrahydrofuran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 125000006168 tricyclic group Chemical group 0.000 description 1
- 239000005051 trimethylchlorosilane Substances 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/04—Carbocyclic radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410392098.XA CN105001213B (zh) | 2014-04-14 | 2014-08-11 | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 |
| EP15780125.9A EP3133071B1 (en) | 2014-04-14 | 2015-04-01 | C-aryl indican derivative, and pharmaceutical composition thereof, preparation method therefor and uses thereof |
| US15/304,493 US9914724B2 (en) | 2014-04-14 | 2015-04-01 | C-aryl glycosid derivatives, pharmaceutical composition, preparation process and uses thereof |
| PCT/CN2015/075651 WO2015158206A1 (zh) | 2014-04-14 | 2015-04-01 | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 |
| JP2017505695A JP6577569B2 (ja) | 2014-04-14 | 2015-04-01 | Ｃ−アリールグリコシド誘導体、その薬物組成物、及び調製方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410148116 | 2014-04-14 | ||
| CN201410148116X | 2014-04-14 | ||
| CN201410392098.XA CN105001213B (zh) | 2014-04-14 | 2014-08-11 | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105001213A CN105001213A (zh) | 2015-10-28 |
| CN105001213B true CN105001213B (zh) | 2020-08-28 |
Family
ID=54323473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410392098.XA Active CN105001213B (zh) | 2014-04-14 | 2014-08-11 | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9914724B2 (enExample) |
| EP (1) | EP3133071B1 (enExample) |
| JP (1) | JP6577569B2 (enExample) |
| CN (1) | CN105001213B (enExample) |
| WO (1) | WO2015158206A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105001213B (zh) | 2014-04-14 | 2020-08-28 | 上海迪诺医药科技有限公司 | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 |
| CN105017236A (zh) * | 2014-04-14 | 2015-11-04 | 上海迪诺医药科技有限公司 | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 |
| CN107922396B (zh) | 2015-07-20 | 2022-08-05 | 建新公司 | 集落刺激因子-1受体(csf-1r)抑制剂 |
| CN106892948B (zh) * | 2015-12-17 | 2022-07-26 | 宜昌东阳光长江药业股份有限公司 | 吡喃葡萄糖基衍生物及其在医药上的应用 |
| CN106928040A (zh) * | 2015-12-31 | 2017-07-07 | 上海医药工业研究院 | Sglt2抑制剂中间体的制备方法 |
| CN107720781B (zh) * | 2017-11-30 | 2018-07-17 | 五莲森之林海藻有限公司 | 一种盐晶颗粒提取设备 |
| WO2019185026A1 (zh) * | 2018-03-30 | 2019-10-03 | 南京明德新药研发有限公司 | 作为SGLTs抑制剂的葡糖苷类衍生物及其应用 |
| CN111471031B (zh) * | 2019-01-24 | 2023-05-16 | 北京盈科瑞创新药物研究有限公司 | 一种糖苷类衍生物及其制备方法和应用 |
| CN111471032B (zh) * | 2019-01-24 | 2023-08-01 | 北京盈科瑞创新药物研究有限公司 | 一种糖苷类衍生物的合成方法及其中间体和应用 |
| MX2022001029A (es) * | 2019-07-26 | 2022-05-24 | Dongbao Purple Star Hangzhou Biopharmaceutical Co Ltd | Inhibidor de sglts/dpp4 y aplicación del mismo. |
| CN111269205B (zh) * | 2020-02-19 | 2023-05-26 | 华侨大学 | 一种c-芳基糖苷化合物的制备方法 |
| CN112961196B (zh) * | 2021-02-07 | 2022-05-31 | 中国人民大学 | 一种糖基和多肽修饰的1,2,3-三唑化合物的制备方法 |
| CN115991702B (zh) * | 2021-12-09 | 2024-02-02 | 珠海市藤栢医药有限公司 | 芳基c-葡萄糖苷衍生物、其制备方法及其用途 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1407990A (zh) * | 1999-10-12 | 2003-04-02 | 布里斯托尔-迈尔斯斯奎布公司 | C－芳基葡糖苷sglt2抑制剂 |
| CN1653075A (zh) * | 2002-05-20 | 2005-08-10 | 百时美施贵宝公司 | C－芳基葡糖苷sglt2抑制剂和方法 |
| CN1275977C (zh) * | 2000-03-30 | 2006-09-20 | 布里斯托尔-迈尔斯斯奎布公司 | O－芳基葡糖苷sglt2抑制剂 |
| CN102643256A (zh) * | 2011-02-18 | 2012-08-22 | 上海璎黎科技有限公司 | 一种芳基糖苷类化合物及其制备方法和应用 |
| CN102875503A (zh) * | 2011-06-25 | 2013-01-16 | 山东轩竹医药科技有限公司 | C-糖苷衍生物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6936590B2 (en) | 2001-03-13 | 2005-08-30 | Bristol Myers Squibb Company | C-aryl glucoside SGLT2 inhibitors and method |
| CA2444481A1 (en) | 2001-04-11 | 2002-10-24 | Bristol-Myers Squibb Company | Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
| EP1581543A4 (en) | 2003-01-03 | 2008-03-19 | Bristol Myers Squibb Co | METHODS FOR PRODUCING SGLT2 GLYCOSIS C-ARYL INHIBITORS |
| ES2567571T3 (es) * | 2003-03-14 | 2016-04-25 | Astellas Pharma Inc. | Derivados de C-glucósido y sales de los mismos |
| KR100942622B1 (ko) | 2003-08-01 | 2010-02-17 | 미쓰비시 타나베 파마 코퍼레이션 | 나트륨-의존성 수송체에 대해 저해 활성을 갖는 신규화합물 |
| EP2360164A3 (de) * | 2004-03-16 | 2012-01-04 | Boehringer Ingelheim International GmbH | Glucopyranosyl-substituierte Benzol-Derivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| ATE453656T1 (de) * | 2005-04-15 | 2010-01-15 | Boehringer Ingelheim Int | Glucopyranosyl-substituierte (heteroaryloxy- benzyl)-benzen-derivate als sglt-inhibitoren |
| BR112012008924A2 (pt) | 2009-10-20 | 2019-09-24 | Novartis Ag | derivado de glicosídeo e usos do mesmo |
| WO2012025857A1 (en) * | 2010-08-23 | 2012-03-01 | Hetero Research Foundation | Cycloalkyl methoxybenzyl phenyl pyran derivatives as sodium dependent glucose co transporter (sglt2) inhibitors |
| CN102453026A (zh) * | 2010-10-27 | 2012-05-16 | 上海艾力斯医药科技有限公司 | C-芳基葡糖苷衍生物、制备方法及其应用 |
| CN104059042B (zh) * | 2013-03-22 | 2017-02-08 | 正大天晴药业集团股份有限公司 | C-三芳基葡萄糖苷类sglt-2抑制剂 |
| CN105017236A (zh) | 2014-04-14 | 2015-11-04 | 上海迪诺医药科技有限公司 | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 |
| CN105001213B (zh) | 2014-04-14 | 2020-08-28 | 上海迪诺医药科技有限公司 | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 |
-
2014
- 2014-08-11 CN CN201410392098.XA patent/CN105001213B/zh active Active
-
2015
- 2015-04-01 WO PCT/CN2015/075651 patent/WO2015158206A1/zh not_active Ceased
- 2015-04-01 JP JP2017505695A patent/JP6577569B2/ja not_active Expired - Fee Related
- 2015-04-01 EP EP15780125.9A patent/EP3133071B1/en active Active
- 2015-04-01 US US15/304,493 patent/US9914724B2/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1407990A (zh) * | 1999-10-12 | 2003-04-02 | 布里斯托尔-迈尔斯斯奎布公司 | C－芳基葡糖苷sglt2抑制剂 |
| CN1275977C (zh) * | 2000-03-30 | 2006-09-20 | 布里斯托尔-迈尔斯斯奎布公司 | O－芳基葡糖苷sglt2抑制剂 |
| CN1653075A (zh) * | 2002-05-20 | 2005-08-10 | 百时美施贵宝公司 | C－芳基葡糖苷sglt2抑制剂和方法 |
| CN102643256A (zh) * | 2011-02-18 | 2012-08-22 | 上海璎黎科技有限公司 | 一种芳基糖苷类化合物及其制备方法和应用 |
| CN102875503A (zh) * | 2011-06-25 | 2013-01-16 | 山东轩竹医药科技有限公司 | C-糖苷衍生物 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20170037038A1 (en) | 2017-02-09 |
| CN105001213A (zh) | 2015-10-28 |
| WO2015158206A1 (zh) | 2015-10-22 |
| JP2017511383A (ja) | 2017-04-20 |
| JP6577569B2 (ja) | 2019-09-18 |
| EP3133071B1 (en) | 2019-12-18 |
| EP3133071A4 (en) | 2017-02-22 |
| EP3133071A1 (en) | 2017-02-22 |
| US9914724B2 (en) | 2018-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105001213B (zh) | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 | |
| JP7773506B2 (ja) | ジフェニルメタン誘導体の製造方法 | |
| TWI588136B (zh) | 多環類衍生物、其製備方法及其在醫藥上的應用 | |
| TWI457122B (zh) | 作為用於治療周邊和中央神經系統疾病之alpha2C拮抗劑的2,3－二氫苯並[1,4]戴奧辛－2－基甲基衍生物 | |
| CN102421767B (zh) | 苯并呋喃衍生物 | |
| CN113474338A (zh) | 吡嗪类衍生物及其在抑制shp2中的应用 | |
| CN104507921B (zh) | 苯并环丁烯类衍生物、其制备方法及其在医药上的应用 | |
| CN105518014B (zh) | C‑芳基葡糖苷衍生物、其制备方法及其在医药上的应用 | |
| RS64259B1 (sr) | Novi derivati fenil propionske kiseline i njihova primena | |
| JP7732999B2 (ja) | アルファ１－アンチトリプシンのモジュレーター | |
| WO1995005374A1 (en) | Fused heteroaromatic cyclopentene derivative having endothelin-antagonist activity | |
| US5420298A (en) | Pyrrolidine derivatives | |
| CN105017236A (zh) | C-芳基糖苷衍生物、其药物组合物、制备方法及应用 | |
| JP2010502648A (ja) | Ｐｐａｒモジュレーターとして有用な１ｈ−インドール−２−カルボン酸誘導体 | |
| WO2020224396A1 (zh) | 抑制tdg活性的化合物 | |
| CN110418790B (zh) | 作为p53-MDM2抑制剂的咪唑并吡咯酮化合物 | |
| TWI439270B (zh) | 苯并咪唑化合物 | |
| KR20090101275A (ko) | 벤조퀴나졸 유도체 | |
| KR20240109240A (ko) | 베타 아드레날린 작용제 및 이의 사용 방법 | |
| CN108203432B (zh) | 吡喃葡萄糖基衍生物及其在医药上的应用 | |
| EA009464B1 (ru) | Бензамиды 4-(аминометил)пиперидина, замещённого гидроксикарбонилфенилом, в качестве антагонистов 5нт-рецепторов | |
| TW202504580A (zh) | Kat6抑制劑 | |
| KR20020093965A (ko) | 항박테리아 활성을 가진 피리미디닐 메틸 인돌 | |
| HK40061204A (en) | Pyrazine derivative and application thereof in inhibiting shp2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |